ProMACE-CytaBOM regimen: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 28: Line 28:


==Indications==
==Indications==
*[[Non-Hodgkin lymphoma]]<ref name="pmid15459544">{{cite journal| author=Isogai R, Kawada A, Hashimoto K, Aragane Y, Tezuka T, Maeda Y et al.| title=Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy. | journal=Dermatology | year= 2004 | volume= 209 | issue= 3 | pages= 243-5 | pmid=15459544 | doi=10.1159/000079901 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15459544 }} </ref
*[[Non-Hodgkin lymphoma]]<ref name="pmid15459544">{{cite journal| author=Isogai R, Kawada A, Hashimoto K, Aragane Y, Tezuka T, Maeda Y et al.| title=Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy. | journal=Dermatology | year= 2004 | volume= 209 | issue= 3 | pages= 243-5 | pmid=15459544 | doi=10.1159/000079901 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15459544 }} </ref>


==References==
==References==

Latest revision as of 19:12, 27 March 2015

WikiDoc Resources for ProMACE-CytaBOM regimen

Articles

Most recent articles on ProMACE-CytaBOM regimen

Most cited articles on ProMACE-CytaBOM regimen

Review articles on ProMACE-CytaBOM regimen

Articles on ProMACE-CytaBOM regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ProMACE-CytaBOM regimen

Images of ProMACE-CytaBOM regimen

Photos of ProMACE-CytaBOM regimen

Podcasts & MP3s on ProMACE-CytaBOM regimen

Videos on ProMACE-CytaBOM regimen

Evidence Based Medicine

Cochrane Collaboration on ProMACE-CytaBOM regimen

Bandolier on ProMACE-CytaBOM regimen

TRIP on ProMACE-CytaBOM regimen

Clinical Trials

Ongoing Trials on ProMACE-CytaBOM regimen at Clinical Trials.gov

Trial results on ProMACE-CytaBOM regimen

Clinical Trials on ProMACE-CytaBOM regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ProMACE-CytaBOM regimen

NICE Guidance on ProMACE-CytaBOM regimen

NHS PRODIGY Guidance

FDA on ProMACE-CytaBOM regimen

CDC on ProMACE-CytaBOM regimen

Books

Books on ProMACE-CytaBOM regimen

News

ProMACE-CytaBOM regimen in the news

Be alerted to news on ProMACE-CytaBOM regimen

News trends on ProMACE-CytaBOM regimen

Commentary

Blogs on ProMACE-CytaBOM regimen

Definitions

Definitions of ProMACE-CytaBOM regimen

Patient Resources / Community

Patient resources on ProMACE-CytaBOM regimen

Discussion groups on ProMACE-CytaBOM regimen

Patient Handouts on ProMACE-CytaBOM regimen

Directions to Hospitals Treating ProMACE-CytaBOM regimen

Risk calculators and risk factors for ProMACE-CytaBOM regimen

Healthcare Provider Resources

Symptoms of ProMACE-CytaBOM regimen

Causes & Risk Factors for ProMACE-CytaBOM regimen

Diagnostic studies for ProMACE-CytaBOM regimen

Treatment of ProMACE-CytaBOM regimen

Continuing Medical Education (CME)

CME Programs on ProMACE-CytaBOM regimen

International

ProMACE-CytaBOM regimen en Espanol

ProMACE-CytaBOM regimen en Francais

Business

ProMACE-CytaBOM regimen in the Marketplace

Patents on ProMACE-CytaBOM regimen

Experimental / Informatics

List of terms related to ProMACE-CytaBOM regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Prednisone-Methotrexate-Adriamycin-Cytoxan-Etoposide-Cytarabine-Bleomycin-Oncovin-Methotrexate Regimen; ProMACE-CytaBOM Regimen

Overview

ProMACE-CytaBOM regimen refers to a regimen consisting of a non-cross resistant regimen consisting of prednisone, methotrexate, doxorubicin, cyclophosphamide and etoposide (ProMACE) alternating with cytarabine, bleomycin, vincristine (oncovin) and methotrexate (CytaBOM), used to treat aggressive forms of non-Hodgkin's lymphoma[1][2]

Regimen

ProPrednisone

MMethotrexate

ADoxorubicin (Adriamycin)

CytaCyclophosphamide

EEtoposide

CytaCytarabine

BBleomycin

OVincristine (Oncovin)

MMethotrexate

Indications

References

  1. 1.0 1.1 Isogai R, Kawada A, Hashimoto K, Aragane Y, Tezuka T, Maeda Y; et al. (2004). "Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy". Dermatology. 209 (3): 243–5. doi:10.1159/000079901. PMID 15459544.
  2. "NCI Thesaurus".